Daehan Nupharm Co.,Ltd. (KOSDAQ:054670)
South Korea · Delayed Price · Currency is KRW 5,680.00
+100.00 (1.79%)
At close: Aug 24, 2026
Daehan Nupharm Market Cap
Daehan Nupharm has a market cap or net worth of 78.32 billion as of August 24, 2026. Its market cap has decreased by -20.85% in one year.
Market Cap
78.32B
Enterprise Value
152.48B
Revenue
205.39B
Ranking
n/a
PE Ratio
5.00
Stock Price
5,680.00
ChartMarket Cap Chart
Since March 3, 2003, Daehan Nupharm's market cap has increased from 13.03B to 78.32B, an increase of 500.96%. That is a compound annual growth rate of 7.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 78.32B | -15.07% |
| Dec 30, 2025 | 92.21B | -4.37% |
| Dec 30, 2024 | 96.42B | -24.09% |
| Dec 28, 2023 | 127.02B | 5.97% |
| Dec 29, 2022 | 119.86B | -21.65% |
| Dec 30, 2021 | 152.98B | -13.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OPTUS Pharmaceutical | 98.82B |
| H.PIO | 85.75B |
| Sam-A Pharm. | 83.55B |
| KOREA PHARMA | 82.24B |
| Polaris AI Pharma | 68.41B |
| Optipharm.CO.,LTD | 66.97B |
| Hwail Pharmaceutical | 66.84B |
| Sinsin Pharmaceutical | 66.30B |